Infectious Disease Molecular Diagnostic Testing

Date: February 22, 2010
Pages: 360
Price:
US$ 2,500.00 US$ 2,125.00
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: I8606CB29FCEN
Leaflet:

Download PDF Leaflet

Infectious Disease Molecular Diagnostic Testing
Global PDF: US$ 5,500.00

The report presents an overview of the clinical significance and market needs for major infectious diseases, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products.

Contains 360 pages and 20 tables
1. OVERVIEW

2. MAJOR INFECTIOUS DISEASES


  * AIDS
    Structure and Composition
    Classification
    AIDS Origins
    Animal Lentivirus Systems
    Virus Receptors
    HIV Infections in Humans
      -Pathogenesis and Pathology
    CD4T Lymphocytes and Memory Cells
    Monocytes and Macrophages
    Lymphoid Organs
    Neural Cells
    Viral Coinfections
      -Clinical Findings
    Plasma Viral Load
    Pediatric AIDS
      -Neurologic Disease
      -Opportunistic Infections
      -Cancer
    Immunity
    Laboratory Diagnosis
      -Virus Isolation
      -Serology
      -Viral Nucleic Acid/Antigen Detection
    Epidemiology
      -Worldwide Spread of AIDS
      -United States
      -Routes of Transmission
    Prevention, Treatment, And Control
      -Antiviral Drugs
      -Vaccines
    Transmission HIV in Blood Products
    HIV Transmission in Transplant and Artificial Insemination Recipients
    Diagnostic Tests
      -Enzyme Immunoassay Interpretation
      -Specificity, Sensitivity and Predictive Value
    Competition Assays
    Western Blot Technique
    Immuno-Fluorescence Assays (IFA)
    Radioimmunoprecipitation
    HIV-1/HIV-2 Combination Testing
    Methods of HIV-Antigen Detection
    Antigen Assays and Blood Screening
    Urine Tests
    DNA Probes
      -Overview
      -Quantitative PCR
      -In Situ PCR
      -Needed Improvements
    Viral Load/Drug Resistance Testing
    Genotype and Phenotype Testing
    Blood Banking Considerations
  * Adenovirus
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Adeno-Associated Viruses (AAV)
  * Anthrax/Bacillus Anthracis
    Background
    Diagnostic Tests
    Vaccines and Drugs
  * Babesiosis
    Background
  * BEA and Other Bartonella Diseases
    Background
    Diagnostic Tests
    Vaccines and Drugs
  * Chagas Disease
    Background
  * Campylobacter
    Background
    Diagnostic Tests
      -Culture Identification
    Vaccines and Drugs
  * Chlamydia
    Background
      -Chlamydia psittaci
      -Chlmaydia pneumoniae
      -Chlamydia trachomatis
    Diagnostic Tests
    Vaccines and Drugs
  * Creutzfeldt-Jakob’s Disease
    Background
    Blood Transmission
    Diagnostic Tests
    Major Commercial and Academic Players
      -Bayer
      -Disease Sciences/Bio Tec Global
      -Imperial College School of Medicine
      -Ortho-Clinical Diagnostics
      -Pall
      -ProMetic Life Sciences
      -Proteome Sciences/Idexx
      -Q-One Biotech
      -Serono
      -U.S. Agricultural Research Service
    Drugs
    Vaccines
  * Cytomegalovirus
    Background
      -Chorioretinitis
      -Gastrointestinal
      -Central Nervous System Disease
    Diagnostic Tests
    Vaccines and Drugs
  * Ebola Virus
    Background
      -Epidemiology
      -Clinical Syndromes
    Diagnostic Tests
    Vaccines and Drugs
  * EchoVirus
    Background
      -Acute Aseptic Meningitisis
      -Encephalitis
      -Exanthems
      -Respiratory Disease
      -Myopericarditis
      -Neonatal Infections
    Diagnostic Tests
    Vaccines and Drugs
  * Encephalitis
    Background
    Diagnostic Tests
    Vaccines and Drugs
  * Enteroviruses
    Background
    Diagnostic Tests
      -Viral Isolation and Identification
      -Antibody Tests
    Vaccines and Drugs
  * Epstein-Barr Virus
    Background
    Diagnostic Tests
    Vaccines and Drugs
  * Gonorrhea
    Background
    Diagnostic Tests
    Vaccines and Drugs
  * Hepatitis
    Hepatitis A
    Hepatitis B
      -Structure and Composition
      -Replication
    Hepatitis C
    Hepatitis D (Delta)
    Hepatitis E
    Hepatitis G
    Hepatitis Infections Pathology
    Clinical Findings
    Laboratory Tests
      -Hepatitis A
      -Hepatitis B
      -Hepatitis C
      -Hepatitis D
      -Hepatitis E
    Virus-Host Immune Reactions
    Epidemiology
      -Hepatitis A
      -Hepatitis B
      -Hepatitis C
      -Hepatitis D (Delta)
    Vaccines and Drugs
  * Herpes Simplex Virus
    Background
    Diagnostic Tests
    Vaccines and Drugs
  * Legionella
    Background
    Diagnostic Tests
    Vaccines and Drugs
  * Lyme Disease
    Background
      -Clinical Description
      -Clinical Case Definition
      -Laboratory Criteria for Diagnosis
      -Case Classification
    Diagnostic Tests
    Vaccines and Drugs
  * Malaria
  * Mycoplasma
    Background
      -Ureaplasma Urealyticum & Mycoplasma Hominis
    Diagnostic Tests
    Vaccines and Drugs
  * Papillomaviruses/HPV
    Background
      -HPV in Cancer
      -Cervical Neoplasm
    Diagnostic Tests
    Vaccines and Drugs
      -Prevention
  * Parvovirus B19
    Background
      -Microbiology
      -Epidemiology
      -Clinical Syndromes
      -Erythema Infectiosum (Slapped Cheek)
      -Adult Polyarthropathy
      -Transient Aplastic Crisis
      -Transient Pancytopenia
      -Red Cell Aplasia in Immunocompromised
      -Perinatal Infections
    Diagnostic Test
    Vaccines and Drugs
  * Pneumonia
    Background
    Diagnostic Tests
    Vaccines and Drugs
  * Polyomaviruses
    Background
    Diagnostic Tests
    Vaccines and Drugs
  * Salmonellosis
    Background
    Diagnostic Tests
    Vaccines and Drugs
  * Shigellosis
    Background
    Diagnostic Tests
    Vaccines and Drugs
  * Streptococci
    Background
    Diagnostic Tests
    Vaccines and Drugs
      -Group A Streptococci
      -Group B Streptococci
  * Toxoplasmosis
    Background
    Diagnostic Tests
    Vaccines and Drugs
  * Tuberculosis
    Background
    Diagnostic Tests
      -Microscopic Characteristics
      -Cultural Characteristics
      -Skin Tests
      -MDRTB
    Vaccines and Drugs
  * West Nile Virus
    Background
      -Clinical Syndromes
    Diagnostic Tests
    Vaccines and Drugs
  * Yersinia
    Background
    Diagnostic Tests
    Vaccines and Drugs

3. ANTIBIOTIC SUSCEPTIBILITY

LIST OF TABLES

Table 1: Major Companies Developing or Marketing AIDS Molecular Diagnostic and other Direct Identification Tests
Table 2: Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and other Direct Identification Tests
Table 3: Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Table 4: Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and other Direct Identification Tests
Table 5: Major Companies Developing or Marketing CMV Molecular Diagnostic and other Direct Identification Tests
Table 6: Major Companies Developing or Marketing EBV Molecular Diagnostic and other Direct Identification Tests
Table 7: Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and other Direct Identification Tests
Table 8: Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and other Direct Identification Tests
Table 9: Major Companies Developing or Marketing Herpes Molecular Diagnostic and other Direct Identification Tests
Table 10: Major Companies Developing or Marketing Legionella Molecular Diagnostic and other Direct Identification Tests
Table 11: Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Table 12: Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and other Direct Identification Tests
Table 13: Major Companies Developing or Marketing Papilloma Virus Molecular Diagnostic and Other Direct Identification Tests
Table 14: Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and other Direct Identification Tests
Table 15: Major Companies Developing or Marketing Salmonella Molecular Diagnostic and other Direct Identification Tests
Table 16: Major Companies Developing or Marketing Shigella Molecular Diagnostic and other Direct Identification Tests
Table 17: Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Table 18: Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Table 19: Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
Table 20: Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Table 21: Major Companies Developing or Marketing Molecular Diagnostic Test for Genetic Diseases
Skip to top


Future Infectious Disease Nucleic Acid Testing US$ 2,125.00 Feb, 2012 · 360 pages
Emerging Cancer Molecular Diagnostic Tests US$ 1,232.50 Dec, 2011 · 45 pages
The 2012 French Molecular Diagnostics Market US$ 5,015.00 Mar, 2012 · 850 pages
The 2012 German Molecular Diagnostics Market US$ 5,015.00 Mar, 2012 · 850 pages
The 2012 Italian Molecular Diagnostics Market US$ 5,015.00 Mar, 2012 · 850 pages

Ask Your Question

Infectious Disease Molecular Diagnostic Testing
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: